Global Radiopharmaceutical Market Research Report 2022(Status and Outlook)
Report Overview
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
The Global Radiopharmaceutical Market Size was estimated at USD 6332.96 million in 2021 and is projected to reach USD 11345.46 million by 2028, exhibiting a CAGR of 8.69% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Radiopharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical market in any manner.
Global Radiopharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
The Global Radiopharmaceutical Market Size was estimated at USD 6332.96 million in 2021 and is projected to reach USD 11345.46 million by 2028, exhibiting a CAGR of 8.69% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Radiopharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical market in any manner.
Global Radiopharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope and Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radiopharmaceutical Market
- Overview of the regional outlook of the Radiopharmaceutical Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Segment by Type
1.2.2 Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Radiopharmaceutical Sales by Manufacturers (2017-2022)
3.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2017-2022)
3.3 Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Radiopharmaceutical Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
6.3 Global Radiopharmaceutical Market Size Market Share by Type (2017-2022)
6.4 Global Radiopharmaceutical Price by Type (2017-2022)
7 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Market Sales by Application (2017-2022)
7.3 Global Radiopharmaceutical Market Size (M USD) by Application (2017-2022)
7.4 Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
8 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY REGION
8.1 Global Radiopharmaceutical Sales by Region
8.1.1 Global Radiopharmaceutical Sales by Region
8.1.2 Global Radiopharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical Basic Information
9.2.2 Bayer Radiopharmaceutical Product Overview
9.2.3 Bayer Radiopharmaceutical Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical Product Market Performance
9.3.4 Mallinckrodt Business Overview
9.3.5 Mallinckrodt Radiopharmaceutical SWOT Analysis
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical Basic Information
9.4.2 Nordion Radiopharmaceutical Product Overview
9.4.3 Nordion Radiopharmaceutical Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Radiopharmaceutical SWOT Analysis
9.4.6 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Radiopharmaceutical SWOT Analysis
9.5.6 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical Basic Information
9.6.2 Lantheus Radiopharmaceutical Product Overview
9.6.3 Lantheus Radiopharmaceutical Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical Basic Information
9.7.2 IBA Group Radiopharmaceutical Product Overview
9.7.3 IBA Group Radiopharmaceutical Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical Basic Information
9.8.2 GE Healthcare Radiopharmaceutical Product Overview
9.8.3 GE Healthcare Radiopharmaceutical Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical Basic Information
9.11.2 Eli Lilly Radiopharmaceutical Product Overview
9.11.3 Eli Lilly Radiopharmaceutical Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical Basic Information
9.13.2 SIEMENS Radiopharmaceutical Product Overview
9.13.3 SIEMENS Radiopharmaceutical Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical Basic Information
9.14.2 Dongcheng Radiopharmaceutical Product Overview
9.14.3 Dongcheng Radiopharmaceutical Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical Basic Information
9.15.2 Navidea Radiopharmaceutical Product Overview
9.15.3 Navidea Radiopharmaceutical Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 RADIOPHARMACEUTICAL MARKET FORECAST BY REGION
10.1 Global Radiopharmaceutical Market Size Forecast
10.2 Global Radiopharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)
11.1 Global Radiopharmaceutical Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2022-2028)
11.1.2 Global Radiopharmaceutical Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Radiopharmaceutical by Type (2022-2028)
11.2 Global Radiopharmaceutical Market Forecast by Application (2022-2028)
11.2.1 Global Radiopharmaceutical Sales (K Units) Forecast by Application
11.2.2 Global Radiopharmaceutical Market Size (M USD) Forecast by Application (2022-2028)
12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceutical Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Radiopharmaceutical Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Radiopharmaceutical Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Radiopharmaceutical Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Radiopharmaceutical Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2021)
Table 10. Global Market Radiopharmaceutical Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Radiopharmaceutical Sales Sites and Area Served
Table 12. Manufacturers Radiopharmaceutical Product Type
Table 13. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radiopharmaceutical
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Market Challenges
Table 22. Market Restraints
Table 23. Global Radiopharmaceutical Sales by Type (K Units)
Table 24. Global Radiopharmaceutical Market Size by Type (M USD)
Table 25. Global Radiopharmaceutical Sales (K Units) by Type (2017-2022)
Table 26. Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
Table 27. Global Radiopharmaceutical Market Size (M USD) by Type (2017-2022)
Table 28. Global Radiopharmaceutical Market Size Share by Type (2017-2022)
Table 29. Global Radiopharmaceutical Price (USD/Unit) by Type (2017-2022)
Table 30. Global Radiopharmaceutical Sales (K Units) by Application
Table 31. Global Radiopharmaceutical Market Size by Application
Table 32. Global Radiopharmaceutical Sales by Application (2017-2022) & (K Units)
Table 33. Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
Table 34. Global Radiopharmaceutical Sales by Application (2017-2022) & (M USD)
Table 35. Global Radiopharmaceutical Market Share by Application (2017-2022)
Table 36. Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
Table 37. Global Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 38. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Table 39. North America Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 40. Europe Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 42. South America Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 44. Bracco Imaging Radiopharmaceutical Basic Information
Table 45. Bracco Imaging Radiopharmaceutical Product Overview
Table 46. Bracco Imaging Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Bracco Imaging Business Overview
Table 48. Bracco Imaging Radiopharmaceutical SWOT Analysis
Table 49. Bracco Imaging Recent Developments
Table 50. Bayer Radiopharmaceutical Basic Information
Table 51. Bayer Radiopharmaceutical Product Overview
Table 52. Bayer Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Bayer Business Overview
Table 54. Bayer Radiopharmaceutical SWOT Analysis
Table 55. Bayer Recent Developments
Table 56. Mallinckrodt Radiopharmaceutical Basic Information
Table 57. Mallinckrodt Radiopharmaceutical Product Overview
Table 58. Mallinckrodt Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Radiopharmaceutical SWOT Analysis
Table 61. Mallinckrodt Recent Developments
Table 62. Nordion Radiopharmaceutical Basic Information
Table 63. Nordion Radiopharmaceutical Product Overview
Table 64. Nordion Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Nordion Business Overview
Table 66. Nordion Radiopharmaceutical SWOT Analysis
Table 67. Nordion Recent Developments
Table 68. Triad Isotopes Radiopharmaceutical Basic Information
Table 69. Triad Isotopes Radiopharmaceutical Product Overview
Table 70. Triad Isotopes Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Triad Isotopes Business Overview
Table 72. Triad Isotopes Radiopharmaceutical SWOT Analysis
Table 73. Triad Isotopes Recent Developments
Table 74. Lantheus Radiopharmaceutical Basic Information
Table 75. Lantheus Radiopharmaceutical Product Overview
Table 76. Lantheus Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Lantheus Business Overview
Table 78. Lantheus Recent Developments
Table 79. IBA Group Radiopharmaceutical Basic Information
Table 80. IBA Group Radiopharmaceutical Product Overview
Table 81. IBA Group Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. IBA Group Business Overview
Table 83. IBA Group Recent Developments
Table 84. GE Healthcare Radiopharmaceutical Basic Information
Table 85. GE Healthcare Radiopharmaceutical Product Overview
Table 86. GE Healthcare Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Recent Developments
Table 89. China Isotope and Radiation Radiopharmaceutical Basic Information
Table 90. China Isotope and Radiation Radiopharmaceutical Product Overview
Table 91. China Isotope and Radiation Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. China Isotope and Radiation Business Overview
Table 93. China Isotope and Radiation Recent Developments
Table 94. Jubilant Pharma Radiopharmaceutical Basic Information
Table 95. Jubilant Pharma Radiopharmaceutical Product Overview
Table 96. Jubilant Pharma Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Jubilant Pharma Business Overview
Table 98. Jubilant Pharma Recent Developments
Table 99. Eli Lilly Radiopharmaceutical Basic Information
Table 100. Eli Lilly Radiopharmaceutical Product Overview
Table 101. Eli Lilly Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Recent Developments
Table 104. Advanced Accelerator Applications Radiopharmaceutical Basic Information
Table 105. Advanced Accelerator Applications Radiopharmaceutical Product Overview
Table 106. Advanced Accelerator Applications Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Advanced Accelerator Applications Business Overview
Table 108. Advanced Accelerator Applications Recent Developments
Table 109. SIEMENS Radiopharmaceutical Basic Information
Table 110. SIEMENS Radiopharmaceutical Product Overview
Table 111. SIEMENS Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. SIEMENS Business Overview
Table 113. SIEMENS Recent Developments
Table 114. Dongcheng Radiopharmaceutical Basic Information
Table 115. Dongcheng Radiopharmaceutical Product Overview
Table 116. Dongcheng Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Dongcheng Business Overview
Table 118. Dongcheng Recent Developments
Table 119. Navidea Radiopharmaceutical Basic Information
Table 120. Navidea Radiopharmaceutical Product Overview
Table 121. Navidea Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Navidea Business Overview
Table 123. Navidea Recent Developments
Table 124. Global Radiopharmaceutical Sales Forecast by Region (K Units)
Table 125. Global Radiopharmaceutical Market Size Forecast by Region (M USD)
Table 126. North America Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 127. North America Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 128. Europe Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 129. Europe Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 130. Asia Pacific Radiopharmaceutical Sales Forecast by Region (2022-2028) & (K Units)
Table 131. Asia Pacific Radiopharmaceutical Market Size Forecast by Region (2022-2028) & (M USD)
Table 132. South America Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 133. South America Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 134. Middle East and Africa Radiopharmaceutical Consumption Forecast by Country (2022-2028) & (Units)
Table 135. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 136. Global Radiopharmaceutical Sales Forecast by Type (2022-2028) & (K Units)
Table 137. Global Radiopharmaceutical Market Size Forecast by Type (2022-2028) & (M USD)
Table 138. Global Radiopharmaceutical Price Forecast by Type (2022-2028) & (USD/Unit)
Table 139. Global Radiopharmaceutical Sales (K Units) Forecast by Application (2022-2028)
Table 140. Global Radiopharmaceutical Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Market Size (M USD), 2017-2028
Figure 5. Global Radiopharmaceutical Market Size (M USD) (2017-2028)
Figure 6. Global Radiopharmaceutical Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Market Size (M USD) by Country (M USD)
Figure 11. Radiopharmaceutical Sales Share by Manufacturers in 2020
Figure 12. Global Radiopharmaceutical Revenue Share by Manufacturers in 2020
Figure 13. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Radiopharmaceutical Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radiopharmaceutical Market Share by Type
Figure 18. Sales Market Share of Radiopharmaceutical by Type (2017-2022)
Figure 19. Sales Market Share of Radiopharmaceutical by Type in 2021
Figure 20. Market Size Share of Radiopharmaceutical by Type (2017-2022)
Figure 21. Market Size Market Share of Radiopharmaceutical by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radiopharmaceutical Market Share by Application
Figure 24. Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
Figure 25. Global Radiopharmaceutical Sales Market Share by Application in 2021
Figure 26. Global Radiopharmaceutical Market Share by Application (2017-2022)
Figure 27. Global Radiopharmaceutical Market Share by Application in 2020
Figure 28. Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
Figure 29. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Figure 30. North America Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 32. U.S. Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Radiopharmaceutical Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Radiopharmaceutical Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Radiopharmaceutical Sales Market Share by Country in 2020
Figure 37. Germany Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2020
Figure 44. China Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 50. South America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 51. Brazil Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Radiopharmaceutical Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Radiopharmaceutical Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Radiopharmaceutical Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Radiopharmaceutical Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Radiopharmaceutical Market Share Forecast by Type (2022-2028)
Figure 65. Global Radiopharmaceutical Sales Forecast by Application (2022-2028)
Figure 66. Global Radiopharmaceutical Market Share Forecast by Application (2022-2028)
1.1 Market Definition and Statistical Scope of Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Segment by Type
1.2.2 Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Radiopharmaceutical Sales by Manufacturers (2017-2022)
3.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2017-2022)
3.3 Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Radiopharmaceutical Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
6.3 Global Radiopharmaceutical Market Size Market Share by Type (2017-2022)
6.4 Global Radiopharmaceutical Price by Type (2017-2022)
7 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Market Sales by Application (2017-2022)
7.3 Global Radiopharmaceutical Market Size (M USD) by Application (2017-2022)
7.4 Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
8 RADIOPHARMACEUTICAL MARKET SEGMENTATION BY REGION
8.1 Global Radiopharmaceutical Sales by Region
8.1.1 Global Radiopharmaceutical Sales by Region
8.1.2 Global Radiopharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical Basic Information
9.2.2 Bayer Radiopharmaceutical Product Overview
9.2.3 Bayer Radiopharmaceutical Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical Product Market Performance
9.3.4 Mallinckrodt Business Overview
9.3.5 Mallinckrodt Radiopharmaceutical SWOT Analysis
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical Basic Information
9.4.2 Nordion Radiopharmaceutical Product Overview
9.4.3 Nordion Radiopharmaceutical Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Radiopharmaceutical SWOT Analysis
9.4.6 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Radiopharmaceutical SWOT Analysis
9.5.6 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical Basic Information
9.6.2 Lantheus Radiopharmaceutical Product Overview
9.6.3 Lantheus Radiopharmaceutical Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical Basic Information
9.7.2 IBA Group Radiopharmaceutical Product Overview
9.7.3 IBA Group Radiopharmaceutical Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical Basic Information
9.8.2 GE Healthcare Radiopharmaceutical Product Overview
9.8.3 GE Healthcare Radiopharmaceutical Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical Basic Information
9.11.2 Eli Lilly Radiopharmaceutical Product Overview
9.11.3 Eli Lilly Radiopharmaceutical Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical Basic Information
9.13.2 SIEMENS Radiopharmaceutical Product Overview
9.13.3 SIEMENS Radiopharmaceutical Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical Basic Information
9.14.2 Dongcheng Radiopharmaceutical Product Overview
9.14.3 Dongcheng Radiopharmaceutical Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical Basic Information
9.15.2 Navidea Radiopharmaceutical Product Overview
9.15.3 Navidea Radiopharmaceutical Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 RADIOPHARMACEUTICAL MARKET FORECAST BY REGION
10.1 Global Radiopharmaceutical Market Size Forecast
10.2 Global Radiopharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)
11.1 Global Radiopharmaceutical Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2022-2028)
11.1.2 Global Radiopharmaceutical Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Radiopharmaceutical by Type (2022-2028)
11.2 Global Radiopharmaceutical Market Forecast by Application (2022-2028)
11.2.1 Global Radiopharmaceutical Sales (K Units) Forecast by Application
11.2.2 Global Radiopharmaceutical Market Size (M USD) Forecast by Application (2022-2028)
12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceutical Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Radiopharmaceutical Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Radiopharmaceutical Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Radiopharmaceutical Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Radiopharmaceutical Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2021)
Table 10. Global Market Radiopharmaceutical Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Radiopharmaceutical Sales Sites and Area Served
Table 12. Manufacturers Radiopharmaceutical Product Type
Table 13. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radiopharmaceutical
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Market Challenges
Table 22. Market Restraints
Table 23. Global Radiopharmaceutical Sales by Type (K Units)
Table 24. Global Radiopharmaceutical Market Size by Type (M USD)
Table 25. Global Radiopharmaceutical Sales (K Units) by Type (2017-2022)
Table 26. Global Radiopharmaceutical Sales Market Share by Type (2017-2022)
Table 27. Global Radiopharmaceutical Market Size (M USD) by Type (2017-2022)
Table 28. Global Radiopharmaceutical Market Size Share by Type (2017-2022)
Table 29. Global Radiopharmaceutical Price (USD/Unit) by Type (2017-2022)
Table 30. Global Radiopharmaceutical Sales (K Units) by Application
Table 31. Global Radiopharmaceutical Market Size by Application
Table 32. Global Radiopharmaceutical Sales by Application (2017-2022) & (K Units)
Table 33. Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
Table 34. Global Radiopharmaceutical Sales by Application (2017-2022) & (M USD)
Table 35. Global Radiopharmaceutical Market Share by Application (2017-2022)
Table 36. Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
Table 37. Global Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 38. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Table 39. North America Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 40. Europe Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 42. South America Radiopharmaceutical Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Radiopharmaceutical Sales by Region (2017-2022) & (K Units)
Table 44. Bracco Imaging Radiopharmaceutical Basic Information
Table 45. Bracco Imaging Radiopharmaceutical Product Overview
Table 46. Bracco Imaging Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Bracco Imaging Business Overview
Table 48. Bracco Imaging Radiopharmaceutical SWOT Analysis
Table 49. Bracco Imaging Recent Developments
Table 50. Bayer Radiopharmaceutical Basic Information
Table 51. Bayer Radiopharmaceutical Product Overview
Table 52. Bayer Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Bayer Business Overview
Table 54. Bayer Radiopharmaceutical SWOT Analysis
Table 55. Bayer Recent Developments
Table 56. Mallinckrodt Radiopharmaceutical Basic Information
Table 57. Mallinckrodt Radiopharmaceutical Product Overview
Table 58. Mallinckrodt Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Radiopharmaceutical SWOT Analysis
Table 61. Mallinckrodt Recent Developments
Table 62. Nordion Radiopharmaceutical Basic Information
Table 63. Nordion Radiopharmaceutical Product Overview
Table 64. Nordion Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Nordion Business Overview
Table 66. Nordion Radiopharmaceutical SWOT Analysis
Table 67. Nordion Recent Developments
Table 68. Triad Isotopes Radiopharmaceutical Basic Information
Table 69. Triad Isotopes Radiopharmaceutical Product Overview
Table 70. Triad Isotopes Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Triad Isotopes Business Overview
Table 72. Triad Isotopes Radiopharmaceutical SWOT Analysis
Table 73. Triad Isotopes Recent Developments
Table 74. Lantheus Radiopharmaceutical Basic Information
Table 75. Lantheus Radiopharmaceutical Product Overview
Table 76. Lantheus Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Lantheus Business Overview
Table 78. Lantheus Recent Developments
Table 79. IBA Group Radiopharmaceutical Basic Information
Table 80. IBA Group Radiopharmaceutical Product Overview
Table 81. IBA Group Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. IBA Group Business Overview
Table 83. IBA Group Recent Developments
Table 84. GE Healthcare Radiopharmaceutical Basic Information
Table 85. GE Healthcare Radiopharmaceutical Product Overview
Table 86. GE Healthcare Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Recent Developments
Table 89. China Isotope and Radiation Radiopharmaceutical Basic Information
Table 90. China Isotope and Radiation Radiopharmaceutical Product Overview
Table 91. China Isotope and Radiation Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. China Isotope and Radiation Business Overview
Table 93. China Isotope and Radiation Recent Developments
Table 94. Jubilant Pharma Radiopharmaceutical Basic Information
Table 95. Jubilant Pharma Radiopharmaceutical Product Overview
Table 96. Jubilant Pharma Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Jubilant Pharma Business Overview
Table 98. Jubilant Pharma Recent Developments
Table 99. Eli Lilly Radiopharmaceutical Basic Information
Table 100. Eli Lilly Radiopharmaceutical Product Overview
Table 101. Eli Lilly Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Recent Developments
Table 104. Advanced Accelerator Applications Radiopharmaceutical Basic Information
Table 105. Advanced Accelerator Applications Radiopharmaceutical Product Overview
Table 106. Advanced Accelerator Applications Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Advanced Accelerator Applications Business Overview
Table 108. Advanced Accelerator Applications Recent Developments
Table 109. SIEMENS Radiopharmaceutical Basic Information
Table 110. SIEMENS Radiopharmaceutical Product Overview
Table 111. SIEMENS Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. SIEMENS Business Overview
Table 113. SIEMENS Recent Developments
Table 114. Dongcheng Radiopharmaceutical Basic Information
Table 115. Dongcheng Radiopharmaceutical Product Overview
Table 116. Dongcheng Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Dongcheng Business Overview
Table 118. Dongcheng Recent Developments
Table 119. Navidea Radiopharmaceutical Basic Information
Table 120. Navidea Radiopharmaceutical Product Overview
Table 121. Navidea Radiopharmaceutical Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Navidea Business Overview
Table 123. Navidea Recent Developments
Table 124. Global Radiopharmaceutical Sales Forecast by Region (K Units)
Table 125. Global Radiopharmaceutical Market Size Forecast by Region (M USD)
Table 126. North America Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 127. North America Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 128. Europe Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 129. Europe Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 130. Asia Pacific Radiopharmaceutical Sales Forecast by Region (2022-2028) & (K Units)
Table 131. Asia Pacific Radiopharmaceutical Market Size Forecast by Region (2022-2028) & (M USD)
Table 132. South America Radiopharmaceutical Sales Forecast by Country (2022-2028) & (K Units)
Table 133. South America Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 134. Middle East and Africa Radiopharmaceutical Consumption Forecast by Country (2022-2028) & (Units)
Table 135. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2022-2028) & (M USD)
Table 136. Global Radiopharmaceutical Sales Forecast by Type (2022-2028) & (K Units)
Table 137. Global Radiopharmaceutical Market Size Forecast by Type (2022-2028) & (M USD)
Table 138. Global Radiopharmaceutical Price Forecast by Type (2022-2028) & (USD/Unit)
Table 139. Global Radiopharmaceutical Sales (K Units) Forecast by Application (2022-2028)
Table 140. Global Radiopharmaceutical Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Market Size (M USD), 2017-2028
Figure 5. Global Radiopharmaceutical Market Size (M USD) (2017-2028)
Figure 6. Global Radiopharmaceutical Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Market Size (M USD) by Country (M USD)
Figure 11. Radiopharmaceutical Sales Share by Manufacturers in 2020
Figure 12. Global Radiopharmaceutical Revenue Share by Manufacturers in 2020
Figure 13. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Radiopharmaceutical Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radiopharmaceutical Market Share by Type
Figure 18. Sales Market Share of Radiopharmaceutical by Type (2017-2022)
Figure 19. Sales Market Share of Radiopharmaceutical by Type in 2021
Figure 20. Market Size Share of Radiopharmaceutical by Type (2017-2022)
Figure 21. Market Size Market Share of Radiopharmaceutical by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radiopharmaceutical Market Share by Application
Figure 24. Global Radiopharmaceutical Sales Market Share by Application (2017-2022)
Figure 25. Global Radiopharmaceutical Sales Market Share by Application in 2021
Figure 26. Global Radiopharmaceutical Market Share by Application (2017-2022)
Figure 27. Global Radiopharmaceutical Market Share by Application in 2020
Figure 28. Global Radiopharmaceutical Sales Growth Rate by Application (2017-2022)
Figure 29. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Figure 30. North America Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 32. U.S. Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Radiopharmaceutical Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Radiopharmaceutical Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Radiopharmaceutical Sales Market Share by Country in 2020
Figure 37. Germany Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2020
Figure 44. China Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 50. South America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 51. Brazil Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Radiopharmaceutical Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Radiopharmaceutical Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Radiopharmaceutical Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Radiopharmaceutical Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Radiopharmaceutical Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Radiopharmaceutical Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Radiopharmaceutical Market Share Forecast by Type (2022-2028)
Figure 65. Global Radiopharmaceutical Sales Forecast by Application (2022-2028)
Figure 66. Global Radiopharmaceutical Market Share Forecast by Application (2022-2028)
